ABOUT
Staff
Our Members
Sponsors
Board of Directors
Contact Us
Issue Areas
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
Personalized Health
FDA Regulations
Resources
Member Resources
Meetings & Events
Newsroom
Letters & Comments
Job Bank
Education
PCOR Training
Health Care Quality
Health Economics 101
Webinars
Blog
Membership
Standards of Excellence
Join Us
Toggle navigation
letters & comments
NHC Comments on ICER Unsupported Price Increase Assessment
February 13, 2019
Read More
NHC Comments on Framework for a Real-World Evidence Program; Availability
February 7, 2019
Read More
NHC Comments on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses
January 25, 2019
Read More
NHC Comments on Patient Engagement in Medical Device Clinical Trials Discussion Document
January 8, 2019
Read More
NHC Comments on Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs
December 31, 2018
Read More
NHC Letter on State Relief and Empowerment Waivers
December 24, 2018
Read More
NHC Comments on Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments
December 14, 2018
Read More
NHC Comments on Accountable Care Organizations Pathways to Success
October 16, 2018
Read More
NHC Comments on FDA Standard Core Clinical Outcome Assessments and Endpoints
October 15, 2018
Read More
« Previous
1
2
3
4
Next »
